Fractionated light PDT therapy for posterior eye disease
AssigneeLight Sciences Oncology, Inc.
InventorsBrian McIlroy, Gregory Heacock, Paula Mahoney, Andrew Hamilton
Life of this patent
Estimating the term…
Abstract
A method and system directs therapeutic light of a first wavelength to a patient's eye to excite a photosensitizing agent for PDT during a series of discrete periods of time that are separated by non-therapeutic intervals. Diagnostic light of a second wavelength can be directed to the eye during at least a portion of one or more of the non-therapeutic intervals to allow a physician to see the affect of the therapy.
Claims28
A method for treating and/or diagnosing a disease of a patient's eye that has been rendered photosensitive by the administration to the patient of a photosensitizing agent comprising:
- directing to the patient's eye for a first predetermined period of time light of a first wavelength or waveband for exciting the photosensitizing agent in the eye;
- stopping the direction of light of the first wavelength or waveband to the eye for a second predetermined period of time;
- and
- resuming the direction of light of the first wavelength or waveband to the patient's eye after the second period of time.
A method for treating and/or diagnosing a disease of a patient's eye that has been rendered photosensitive by the administration to the patient of a photosensitizing agent comprising:
- directing to the patient's eye for a first period of time therapeutic light of a first energy level for exciting the administered photosensitizing agent to undergo a photochemical interaction with oxygen;
- reducing, for a second predetermined period of time following the first period of time, the energy level of therapeutic light directed to the eye to a level that allows the eye to re-oxygenate;
- and
- resuming the direction of light of the first energy level after the second period of time.
A method for treating and/or diagnosing a disease of a patient's eye that has been rendered photosensitive by the administration to the patient of a photosensitizing agent comprising:
- directing to the patient's eye for a first predetermined period of time therapeutic light of a first wavelength or waveband for exciting a first photosensitizing agent;
- directing to the patient's eye for a second predetermined period of time diagnostic light of a second wavelength or waveband for exciting a second photosensitizing agent, the diagnostic light being directed to the eye at a time after the end of the first period of time;
- and
- resuming the direction of the therapeutic light to the patient's eye at a time after the end of the second period of time.
A method for treating and/or diagnosing a disease of a patient's eye comprising:
- administering a photosensitizing agent to a patient, the photosensitizing agent being absorbed in targeted eye tissue;
- and
- directing therapeutic light to a patient's eye to excite the photosensitizing agent in the targeted tissue during a series of discrete periods of time that are separated by non-therapeutic intervals.
A system for directing light to an eye to which at least one photosensitizing agent has been administered comprising:
- a source of therapeutic light of a first wavelength or waveband, the therapeutic light source being controlled to emit the therapeutic light during a series of discrete periods of time that are separated by non-therapeutic intervals;
- a partial reflector for reflecting the therapeutic light of the first wavelength or waveband towards an eye and passing light of other wavelengths therethrough;
- and
- a source of diagnostic light of a second wavelength, the diagnostic light being directed to the patient's eye during at least a portion of one of the non-therapeutic intervals.
Dependencies are inferred from the claim text.